In vitro methodology for medical device material thrombogenicity assessments: A use condition and bioanalytical proof‐of‐concept approach

Device manufacturers and regulatory agencies currently utilize expensive and often inconclusive in vivo vascular implant models to assess implant material thrombogenicity. We report an in vitro thrombogenicity assessment methodology where test materials (polyethylene, Elasthane™ 80A polyurethane, Pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolf, Michael F., Girdhar, Gaurav, Anderson, Arielle A., Ubl, Samantha R., Thinamany, Sinduja, Jeffers, Hannah N., DeRusha, Courtney E., Rodriguez‐Fernandez, Jenny, Hoffmann, Sebastian, Strief, Carrie A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Original Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821245/
https://www.ncbi.nlm.nih.gov/pubmed/32929881
http://dx.doi.org/10.1002/jbm.b.34705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821245/
https://www.ncbi.nlm.nih.gov/pubmed/32929881
http://dx.doi.org/10.1002/jbm.b.34705

Ejemplares similares